{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:33:17Z","timestamp":1794501197729,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijcard.2024.131813","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T19:15:42Z","timestamp":1706123742000},"page":"131813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"402","author":[{"given":"Yu","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.131813_bb0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/HYPERTENSIONAHA.120.15323","article-title":"Prior Beta-blocker therapy for hypertension and sex-based differences in heart failure among patients with incident coronary heart disease","volume":"76","author":"Bugiardini","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.ijcard.2024.131813_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12916-020-01564-3","article-title":"Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment","volume":"18","author":"Ziff","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.ijcard.2024.131813_bb0015","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2023.04.021","article-title":"Association of Beta-Blocker Therapy with Cardiovascular Outcomes in patients with stable ischemic heart disease","volume":"81","author":"Godoy","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131813_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of Arrhythmias in cardiac amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2024.131813_bb0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.131813_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cpcardiol.2012.11.002","article-title":"Current trends in diagnosis and management of cardiac amyloidosis","volume":"38","author":"Esplin","year":"2013","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131813_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2024.131813_bb0040","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis","volume":"68","author":"Falk","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131813_bb0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/13506129.2016.1272453","article-title":"Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?","volume":"24","author":"Aus dem Siepen","year":"2017","journal-title":"Amyloid."},{"key":"10.1016\/j.ijcard.2024.131813_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022859","article-title":"Lack of association between neurohormonal blockade and survival in transthyretin cardiac amyloidosis","volume":"10","author":"Cheng","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.131813_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mayocp.2021.08.006","article-title":"Beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy","volume":"97","author":"Barge-Caballero","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijcard.2024.131813_bb0060","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","article-title":"Conventional heart failure therapy in cardiac ATTR amyloidosis","volume":"44","author":"Ioannou","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.131813_bb0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2024.131813_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejim.2020.05.015","article-title":"Safety and tolerability of Neurohormonal antagonism in cardiac amyloidosis","volume":"80","author":"Aimo","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2024.131813_bb0075","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1002\/ehf2.13411","article-title":"Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey","volume":"8","author":"Tini","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2024.131813_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.907597","article-title":"Beta-adrenergic antagonist tolerance in amyloid cardiomyopathy","volume":"9","author":"Ramsell","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2024.131813_bb0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.amjcard.2023.07.140","article-title":"Safety and efficacy of traditional heart failure therapies in patients with cardiac amyloidosis and heart failure","volume":"204","author":"Yan","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131813_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13506129.2021.1981281","article-title":"Utilization and tolerance of beta-blockers among patients with AL amyloidosis","volume":"29","author":"Briasoulis","year":"2022","journal-title":"Amyloid."},{"key":"10.1016\/j.ijcard.2024.131813_bb0095","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.131813_bb0100","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2024.131813_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255487","article-title":"Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis","volume":"16","author":"Itzhaki Ben Zadok","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2024.131813_bb0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/europace\/euad010","article-title":"Beta-blockers in atrial fibrillation-trying to make sense of unsettling results","volume":"25","author":"Meyer","year":"2023","journal-title":"Europace."},{"key":"10.1016\/j.ijcard.2024.131813_bb0115","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2022.23","article-title":"Pathophysiological rationale and clinical evidence for Neurohormonal modulation in heart failure with preserved ejection fraction","volume":"9","author":"Castiglione","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"10.1016\/j.ijcard.2024.131813_bb0120","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/eurheartj\/ehad357","article-title":"Neurohormonal blockade in transthyretin amyloidosis: perhaps one size does not fit all?","volume":"44","author":"Cheng","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.131813_bb0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13506129.2021.1966624","article-title":"Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure","volume":"28","author":"Vergaro","year":"2021","journal-title":"Amyloid."},{"key":"10.1016\/j.ijcard.2024.131813_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020358","article-title":"Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis","volume":"10","author":"Pucci","year":"2021","journal-title":"J. Am. Heart Assoc."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324001785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324001785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:04:15Z","timestamp":1759093455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324001785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":26,"alternative-id":["S0167527324001785"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131813","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131813"}}